Alterity Therapeutics Limited
PRNAF
$0.0088
-$0.0013-12.87%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -60.01% | -47.91% | -35.16% | -7.59% | 17.60% |
| Total Depreciation and Amortization | 15.29% | 27.50% | 40.49% | 51.26% | 68.07% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 449.29% | 576.83% | 941.18% | 200.53% | 122.06% |
| Change in Net Operating Assets | 176.07% | 184.29% | 187.67% | 161.25% | -262.38% |
| Cash from Operations | -11.21% | 16.97% | 38.65% | 21.38% | -5.11% |
| Capital Expenditure | 100.00% | 62.75% | 22.45% | 86.86% | 91.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 3.00% | -- |
| Cash from Investing | 100.00% | 92.34% | 84.55% | 68.22% | 61.74% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 72.64% | 76.73% | 82.67% | 1.22% | -125.39% |
| Issuance of Common Stock | 489.48% | 931.46% | 3,104.23% | 2,527.08% | 1,108.39% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -123.79% | -265.35% | -593.35% | -391.49% | -162.67% |
| Cash from Financing | 631.24% | 1,272.79% | 7,116.55% | 10,292.68% | 4,008.21% |
| Foreign Exchange rate Adjustments | -53.26% | -65.62% | -72.18% | -76.68% | -78.39% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 41.00% | 66.10% | 84.03% | 48.62% | -9.94% |
